Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03336411 · ClinicalTrials.gov registry record · NA
A Personalized Diet Study to Reduce Glycemic Exposure
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 269
- Enrollment target
NCT03336411 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 269 participants.
The verdict
NCT03336411, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 269 participants
- Enrollment target
Study Summary
The aim of this 2-phase, randomized clinical trial will be to examine the effects of two behavioral weight loss interventions on weight loss. This study will be conducted in 200 overweight or obese prediabetic individuals recruited from community-based settings.. Phase 1 will include 6-months of active intervention. Phase 2 will consist of 6-months of maintenance and observation. Measurements will occur at screening, baseline, 3, 6, and 12 months. Participants will be randomized with equal allocation to 2 groups: (1) a standardized behavioral weight loss intervention with a one-size-fits-all regimen that includes counseling about restriction of calories and calories from fat, and physical activity, delivered using mHealth technology, or (2) all of the elements of mHealth, plus personalized dietary recommendations to minimize glycemic response to meals. Participants will be required to attend 6 separate visits over both phases of the study.
Interventions
- BEHAVIORAL mHealth
- BEHAVIORAL Personalized mHealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2017-12-12 |
| Est. Completion | 2021-10-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03336411
The ClinicalTrials.gov registry entry for NCT03336411 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 269 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which mHealth is the first listed.
NCT03336411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03336411 about?
NCT03336411 is a clinical study titled "A Personalized Diet Study to Reduce Glycemic Exposure". The aim of this 2-phase, randomized clinical trial will be to examine the effects of two behavioral weight loss interventions on weight loss. This study will be conducted in 200 overweight or obese prediabetic individuals recruited from community-based settings.. Phase 1 will include 6-months of act...
What is the current status of trial NCT03336411?
This trial is currently completed. It is a NA study. The enrollment target is 269 participants. The study started on 2017-12-12. Estimated completion is 2021-10-27.
What interventions are being tested in trial NCT03336411?
The interventions under investigation include: mHealth (BEHAVIORAL), Personalized mHealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT03336411?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.